1. Palmieri LJ, Dermine S, Coriat R. Potential Areas of Interest in a Trial of Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin for Hepatocellular Carcinoma. JAMA Oncol 2019;5:1805-1806.
2. Ding ZB, Hui B, Shi YH, Zhou J, Peng YF, Gu CY, Yang H, et al. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clin Cancer Res 2011;17:6229-6238.
3. Cai Q, Wang S, Jin L, Weng M, Zhou D, Wang J, Tang Z, et al. Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. Mol Cancer 2019;18:82.
4. Amaravadi RK, Kimmelman AC, Debnath J. Targeting Autophagy in Cancer: Recent Advances and Future Directions. Cancer Discov 2019;9:1167-1181.
5. Ou J, Peng Y, Yang W, Zhang Y, Hao J, Li F, Chen Y, et al. ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield. Nat Commun 2019;10:1078.
6. Chang YS, Jalgaonkar SP, Middleton JD, Hai T. Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis. Proc Natl Acad Sci U S A 2017;114:E7159-e7168.
7. Keklikoglou I, Cianciaruso C, Güç E, Squadrito ML, Spring LM, Tazzyman S, Lambein L, et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat Cell Biol 2019;21:190-202.
8. Fong MY, Zhou W, Liu L, Alontaga AY, Chandra M, Ashby J, Chow A, et al. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol 2015;17:183-194.
9. Bryant KL, Stalnecker CA, Zeitouni D, Klomp JE, Peng S, Tikunov AP, Gunda V, et al. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med 2019;25:628-640.
10. Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, et al. Protective autophagy elicited by RAF-->MEK-->ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med 2019;25:620-627.
11. Chen M, Yang D, Sun Y, Liu T, Wang W, Fu J, Wang Q, et al. In Situ Self-Assembly Nanomicelle Microneedles for Enhanced Photoimmunotherapy via Autophagy Regulation Strategy. ACS Nano 2021;15:3387-3401.
12. Venturelli S, Berger A, Weiland T, Zimmermann M, Häcker S, Peter C, Wesselborg S, et al. Dual antitumour effect of 5-azacytidine by inducing a breakdown of resistance-mediating factors and epigenetic modulation. Gut 2011;60:156-165.
13. Ruiz de Galarreta M, Bresnahan E, Molina-Sánchez P, Lindblad KE, Maier B, Sia D, Puigvehi M, et al. β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma. Cancer Discov 2019;9:1124-1141.
14. Gump JM, Staskiewicz L, Morgan MJ, Bamberg A, Riches DWH, Thorburn A. Autophagy variation within a cell population determines cell fate through selective degradation of Fap-1. Nature Cell Biology 2014;16:47-54.
15. Huang X, Gan G, Wang X, Xu T, Xie W. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance. Autophagy 2019;15:1258-1279.
16. Xu WP, Liu JP, Feng JF, Zhu CP, Yang Y, Zhou WP, Ding J, et al. miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy. Gut 2020;69:1309-1321.
17. Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY, Hui B, Zhou J, et al. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Autophagy 2013;9:2056-2068.
18. Liu C, Sun L, Yang J, Liu T, Yang Y, Kim SM, Ou X, et al. FSIP1 regulates autophagy in breast cancer. Proc Natl Acad Sci U S A 2018;115:13075-13080.
19. Wang Y, Yin S, Zhang L, Shi K, Tang J, Zhang Z, He Q. A tumor-activatable particle with antimetastatic potential in breast cancer via inhibiting the autophagy-dependent disassembly of focal adhesion. Biomaterials 2018;168:1-9.
20. Sharifi MN, Mowers EE, Drake LE, Collier C, Chen H, Zamora M, Mui S, et al. Autophagy Promotes Focal Adhesion Disassembly and Cell Motility of Metastatic Tumor Cells through the Direct Interaction of Paxillin with LC3. Cell Rep 2016;15:1660-1672.
21. Liu H, Ma Y, He HW, Zhao WL, Shao RG. SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells. Autophagy 2017;13:900-913.
22. Ma H, Li Y, Wang X, Wu H, Qi G, Li R, Yang N, et al. PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma. Cell Death Dis 2019;10:166.
23. Karagiannis GS, Pastoriza JM, Wang Y, Harney AS, Entenberg D, Pignatelli J, Sharma VP, et al. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism. Sci Transl Med 2017;9.
24. Zhang F, Wang H, Yu J, Yao X, Yang S, Li W, Xu L, et al. LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM. Mol Cancer 2021;20:6.
25. Hu F, Song D, Yan Y, Huang C, Shen C, Lan J, Chen Y, et al. IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation. Nature Communications 2021;12:3651.
26. Xin X, Du X, Xiao Q, Azevedo HS, He W, Yin L. Drug Nanorod-Mediated Intracellular Delivery of microRNA-101 for Self-sensitization via Autophagy Inhibition. Nanomicro Lett 2019;11:82.
27. Xu F, Li X, Huang X, Pan J, Wang Y, Zhou S. Development of a pH-responsive polymersome inducing endoplasmic reticulum stress and autophagy blockade. Sci Adv 2020;6:eabb8725.
28. Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema KJ, Coppes RP, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 2018;14:1435-1455.
29. Ji Y, Liu X, Li J, Xie X, Huang M, Jiang J, Liao YP, et al. Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment. Nat Commun 2020;11:4249.
30. Ruan S, Xie R, Qin L, Yu M, Xiao W, Hu C, Yu W, et al. Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment. Nano Lett 2019;19:8318-8332.
31. Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer 2017;17:528-542.
32. Padmanaban V, Krol I, Suhail Y, Szczerba BM, Aceto N, Bader JS, Ewald AJ. E-cadherin is required for metastasis in multiple models of breast cancer. Nature 2019;573:439-444.
33. Nguyen-Ngoc KV, Cheung KJ, Brenot A, Shamir ER, Gray RS, Hines WC, Yaswen P, et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc Natl Acad Sci U S A 2012;109:E2595-2604.
34. Zhou W, Gong L, Wu Q, Xing C, Wei B, Chen T, Zhou Y, et al. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 2018;37:215.
35. He M, Li Q, Zou R, Shen J, Fang W, Tan G, Zhou Y, et al. Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial. JAMA Oncol 2019;5:953-960.
36. Selvakumaran M, Amaravadi RK, Vasilevskaya IA, O'Dwyer PJ. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin Cancer Res 2013;19:2995-3007.
37. Wang X, Li M, Ren K, Xia C, Li J, Yu Q, Qiu Y, et al. On-Demand Autophagy Cascade Amplification Nanoparticles Precisely Enhanced Oxaliplatin-Induced Cancer Immunotherapy. Adv Mater 2020;32:e2002160.
38. Yong T, Zhang X, Bie N, Zhang H, Zhang X, Li F, Hakeem A, et al. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nat Commun 2019;10:3838.
39. Lv P, Liu X, Chen X, Liu C, Zhang Y, Chu C, Wang J, et al. Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy. Nano Lett 2019;19:2993-3001.
40. Liu X, Liu C, Zheng Z, Chen S, Pang X, Xiang X, Tang J, et al. Vesicular Antibodies: A Bioactive Multifunctional Combination Platform for Targeted Therapeutic Delivery and Cancer Immunotherapy. Adv Mater 2019;31:e1808294.
41. Zhang P, Zhang L, Qin Z, Hua S, Guo Z, Chu C, Lin H, et al. Genetically Engineered Liposome-like Nanovesicles as Active Targeted Transport Platform. Adv Mater 2018;30.
42. Shi Y, Xie F, Rao P, Qian H, Chen R, Chen H, Li D, et al. TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy. J Control Release 2020;320:304-313.
43. Shi Y, Wang J, Liu J, Lin G, Xie F, Pang X, Pei Y, et al. Oxidative stress-driven DR5 upregulation restores TRAIL/Apo2L sensitivity induced by iron oxide nanoparticles in colorectal cancer. Biomaterials 2020;233:119753.
44. Shi Y, Pang X, Wang J, Liu G. NanoTRAIL-Oncology: A Strategic Approach in Cancer Research and Therapy. Adv Healthc Mater 2018;7:e1800053.
45. Liu X, Yuan L, Zhang L, Mu Y, Li X, Liu C, Lv P, et al. Bioinspired Artificial Nanodecoys for Hepatitis B Virus. Angew Chem Int Ed Engl 2018;57:12499-12503.
46. Zhang P, Wang J, Chen H, Zhao L, Chen B, Chu C, Liu H, et al. Tumor Microenvironment-Responsive Ultrasmall Nanodrug Generators with Enhanced Tumor Delivery and Penetration. Journal of the American Chemical Society 2018;140:14980-14989.
47. Chu C, Ren E, Zhang Y, Yu J, Lin H, Pang X, Zhang Y, et al. Zinc(II)-Dipicolylamine Coordination Nanotheranostics: Toward Synergistic Nanomedicine by Combined Photo/Gene Therapy. Angew Chem Int Ed Engl 2019;58:269-272.
48. Chen Y, Chen Y, Zhang J, Cao P, Su W, Deng Y, Zhan N, et al. Fusobacterium nucleatum Promotes Metastasis in Colorectal Cancer by Activating Autophagy Signaling via the Upregulation of CARD3 Expression. Theranostics 2020;10:323-339.